HOXA9 is linked to impaired differentiation of hematopoietic precursor cells and is frequently activated in mixed-lineage leukemia (MLL)-related AML and ALL, T-cell acute lymphoblastic leukemia (T-ALL) and in Nup98-rearranged AML (reviewed in [102]). Here, NUP98 is linked to acute lymphoblastic leukemia.